Finding the right dosage of a psychotropic may be notoriously time consuming, but thought should be granted to the sexually dimorphic expression of CYP450 enzymes when prescribing medication.
Anita S. Kablinger, MD
Advertisement
Articles by Anita S. Kablinger, MD
Biological Markers and the Future of Early Diagnosis and Treatment in Schizophrenia
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Issues CRL for CTx-1301 for Treatment of ADHD
2
Insights Into Mechanism-Based Biomarkers for Psychosis Prediction from Kim Do, PhD
3
New Name, New Path for Psychiatry: The Future of the DSM
4
Nonpharmacological Augmentation of Ketamine, Neuroplasticity, and Behavioral Therapy
5